bpc-157 dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or How to Take BPC 157
Description
I can see a difference

Note, BPC 157 therapy might have a direct effect on observable potassium conductance in HEK293 cells

When injecting insulin with an EasyTouch syringe, follow standard insulin injection technique

If the breakouts reduce, it may be something in the supplement
